Advertisement
Screener

ANIXA BIOSCIENCES, INC. (ANIX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ANIXA BIOSCIENCES, INC. Cash Flow Breakdown

Cash flow breakdown shows where ANIXA BIOSCIENCES, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-10-31: from running the business, $7.17M went out.
  • Fiscal year ended 2025-10-31: from investing, $4.87M came in.
  • Fiscal year ended 2025-10-31: from financing, $2.28M came in.
  • Fiscal year ended 2025-10-31: change in cash, $27.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-10-31-$7.17M$4.87M$2.38M-$27.00K
2024-10-31-$7.33M$4.28M$2.96M$356.00K
2023-10-31-$6.21M-$5.60M$353.00K-$11.45M
2022-10-31-$6.49M-$10.73M$439.00K-$16.77M
2021-10-31-$4.94M-$3.92M$10.83M$20.73M*$22.71M
2020-10-31-$6.18M-$305.79K$9.27M$2.93M
2019-10-31-$4.74M-$525.46K$5.53M$435.74K
2018-10-31-$4.27M$1.46M$2.47M-$283.48K
2017-10-31-$3.80M-$2.74M$3.46M$3.92M*$851.05K
2016-10-31-$3.38M$1.50M$33.58K-$1.88M
2015-10-31$1.36M$45.22K$44.63K$1.01M
2014-10-31-$2.38M-$2.51M$3.67M$3.68M*$2.46M
2013-10-31-$3.19M$499.32K$1.05M$2.20M*$558.48K
2012-10-31-$3.14M$1.75M$208.45K$750.00K*-$434.35K
2011-10-31-$716.00K-$2.14M$1.28M$1.25M*-$320.08K
2010-10-31-$2.41M$799.69K$1.25M-$357.13K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-07-31-$1.77M*-$245.00K*$1.94M*
2026-04-30-$1.74M*$422.00K*$0.00*$1.25M*
2026-01-31-$2.61M$1.23M$60.00K$1.63M*$303.00K
2025-10-31-$1.25M*$654.00K*$454.00K*
2025-07-31-$1.51M*-$833.00K*$1.93M*
2025-04-30-$1.50M*$2.34M*$14.00K*
2025-01-31-$2.90M$2.70M-$17.00K-$218.00K
2024-10-31-$927.00K*$867.00K*-$29.00K*
2024-07-31-$2.64M*$2.72M*-$45.00K*
2024-04-30-$1.46M*$556.00K*$833.00K*
2024-01-31-$2.31M$129.00K$2.20M$83.00K
2023-10-31-$1.97M*-$593.00K*$272.00K*
2023-07-31-$1.45M*-$980.00K*$3.00K*
2023-04-30-$807.00K*-$3.44M*$75.00K*
2023-01-31-$1.99M-$585.00K$3.00K-$2.57M
2022-10-31-$1.59M*-$9.92M*-$391.00K*
2022-07-31-$1.40M*-$2.91M*-$1.00K*$830.00K*
2022-04-30-$2.31M*$250.00K*
2022-01-31-$1.20M$1.85M$653.00K
2021-10-31-$1.04M*$2.81M*-$341.00K*
2021-07-31-$1.48M*$1.00M*$0.00*
2021-04-30-$1.24M*-$8.40M*$5.22M*$20.14M*
2021-01-31-$1.17M$675.00K$5.96M$5.57M
2020-10-31-$1.41M*$500.00K*$1.09M*
2020-07-31-$1.29M*-$520.00K*$4.99M*
2020-04-30-$1.56M*$250.00K*$1.44M*
2020-01-31-$1.91M-$535.79K$1.75M-$669.74K
2019-10-31-$1.34M*-$250.00K*$627.68K*
2019-07-31-$640.10K*$650.00K*$541.94K*
2019-04-30-$1.43M*-$1.18M*$2.20M*-$330.33K*
2019-01-31-$1.33M$250.00K$2.15M$1.10M
2018-10-31-$1.02M*$743.45K*$684.15K*$464.79K*
2018-07-31-$1.17M*-$1.52M*$1.11M*-$1.58M*
2018-04-30-$742.49K*$1.39M*$1.33M*
2018-01-31-$1.34M$847.48K-$492.51K
2017-10-31-$739.29K*$782.70K*$1.61K*$1.46M*$1.51M*
2017-07-31-$1.25M*-$2.00M*$0.00*$2.21M*-$1.04M*
2017-04-30-$1.08M*-$1.65M*$0.00*$4.20M*$1.48M*
2017-01-31-$729.91K$135.88K$5.67K*-$1.09M
2016-10-31-$682.99K*$1.15M*$10.20K*$439.08K*
2016-07-31-$814.69K*$246.46K*$5.15K*-$563.08K*
2016-04-30-$1.35M*-$35.10K*-$1.37M*
2016-01-31-$532.38K$143.99K-$388.39K
2015-10-31-$801.92K*$0.00*$10.30K*-$791.63K*
2015-07-31-$708.55K*$0.00*-$919.47K*
2015-04-30-$1.78M*$250.00K*-$1.73M*
2015-01-31$4.65M-$204.78K$4.45M
2014-10-31-$362.08K*$47.11K*$0.00*-$290.32K*
2014-07-31-$337.35K*-$502.47K*$50.50K*$3.82M*$3.03M*
2014-04-30-$507.80K*$398.67K*-$158.42K*
2014-01-31-$1.17M-$2.45M$3.50M*-$122.03K
2013-10-31-$544.40K*$0.00*$460.54K*-$83.86K*
2013-07-31-$839.66K*-$1.10K*$131.54K*-$291.72K*
2013-04-30-$912.73K*$1.75K*-$439.60K*
2013-01-31-$890.01K$498.67K$1.76M*$1.37M
2012-10-31-$962.44K*$450.60K*$0.00*$750.00K*$238.16K*
2012-07-31-$628.44K*$599.24K*$0.00*-$29.20K*
2012-04-30-$892.61K*$499.10K*$61.20K*-$332.31K*
2012-01-31-$657.26K$199.00K$147.25K-$311.00K
2011-10-31-$712.49K*$749.88K*$185.25K*$222.64K*
2011-07-31$1.33M*-$1.65M*$521.45K*$204.30K*
2011-04-30-$726.07K*-$1.26M*$99.55K*$1.25M*-$631.86K*
2011-01-31-$609.65K$16.64K$477.85K-$115.16K
2010-10-31-$517.14K*$2.80K*$199.50K*-$314.84K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ProMIS Neurosciences Inc. (PMN)$0.102B
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92